- Home
- OLO vs PLSE Comparison
OLO vs PLSE Comparison
Compare OLO & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLO
- PLSE
- Stock Information
- Founded
- OLO 2005
- PLSE 2014
- Country
- OLO United States
- PLSE United States
- Employees
- OLO N/A
- PLSE N/A
- Industry
- OLO Major Banks
- PLSE Medical/Dental Instruments
- Sector
- OLO Finance
- PLSE Health Care
- Exchange
- OLO Nasdaq
- PLSE Nasdaq
- Market Cap
- OLO 1.1B
- PLSE 1.0B
- IPO Year
- OLO 2021
- PLSE 2016
- Fundamental
- Price
- OLO $7.00
- PLSE $16.12
- Analyst Decision
- OLO Strong Buy
- PLSE
- Analyst Count
- OLO 3
- PLSE 0
- Target Price
- OLO $8.33
- PLSE N/A
- AVG Volume (30 Days)
- OLO 1.7M
- PLSE 194.1K
- Earning Date
- OLO 11-07-2024
- PLSE 10-30-2024
- Dividend Yield
- OLO N/A
- PLSE N/A
- EPS Growth
- OLO N/A
- PLSE N/A
- EPS
- OLO N/A
- PLSE N/A
- Revenue
- OLO $271,872,000.00
- PLSE N/A
- Revenue This Year
- OLO $24.04
- PLSE N/A
- Revenue Next Year
- OLO $15.37
- PLSE N/A
- P/E Ratio
- OLO N/A
- PLSE N/A
- Revenue Growth
- OLO 26.41
- PLSE N/A
- 52 Week Low
- OLO $4.20
- PLSE $6.60
- 52 Week High
- OLO $7.13
- PLSE $22.69
- Technical
- Relative Strength Index (RSI)
- OLO 77.85
- PLSE 44.34
- Support Level
- OLO $6.32
- PLSE $16.05
- Resistance Level
- OLO $6.54
- PLSE $17.20
- Average True Range (ATR)
- OLO 0.36
- PLSE 1.22
- MACD
- OLO 0.08
- PLSE -0.16
- Stochastic Oscillator
- OLO 93.75
- PLSE 31.09
About OLO Olo Inc.
Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.